These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20010066)

  • 1. Use of magnetic resonance imaging contrast agents to detect transplanted liver cells.
    Puppi J; Modo M
    Top Magn Reson Imaging; 2009 Apr; 20(2):113-20. PubMed ID: 20010066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver cell labelling with MRI contrast agents.
    Modo M; Meade TJ; Mitry RR
    Methods Mol Biol; 2009; 481():207-19. PubMed ID: 19096799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW; Kraitchman DL
    NMR Biomed; 2004 Nov; 17(7):484-99. PubMed ID: 15526347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.
    Beckmann N; Cannet C; Babin AL; Blé FX; Zurbruegg S; Kneuer R; Dousset V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):272-98. PubMed ID: 20049797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging contrast media for visualization of liver function.
    Yoshinori M; Masaharu M; Yuri H; Sayoko N; Nao S; Makoto H
    Magn Reson Imaging; 2010 Jun; 28(5):708-15. PubMed ID: 20378293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.
    Shen J; Zhong XM; Duan XH; Cheng LN; Hong GB; Bi XB; Liu Y
    Acad Radiol; 2009 Sep; 16(9):1142-54. PubMed ID: 19660710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking transplanted cells by MRI - methods and protocols.
    Modo M
    Methods Mol Biol; 2011; 771():717-32. PubMed ID: 21874504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging platform for tracking immunotherapeutic cells.
    Ahrens ET; Flores R; Xu H; Morel PA
    Nat Biotechnol; 2005 Aug; 23(8):983-7. PubMed ID: 16041364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive imaging of transplanted cells.
    Modo M
    Curr Opin Organ Transplant; 2008 Dec; 13(6):654-8. PubMed ID: 19060558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive cell tracking.
    Kiessling F
    Handb Exp Pharmacol; 2008; (185 Pt 2):305-21. PubMed ID: 18626608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation.
    Bulte JW; Duncan ID; Frank JA
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):899-907. PubMed ID: 12172375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
    Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
    Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging.
    Lee ES; Chan J; Shuter B; Tan LG; Chong MS; Ramachandra DL; Dawe GS; Ding J; Teoh SH; Beuf O; Briguet A; Tam KC; Choolani M; Wang SC
    Stem Cells; 2009 Aug; 27(8):1921-31. PubMed ID: 19544438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of transplanted cells within the myocardium.
    Ruhparwar A; Ghodsizad A; Lichtenberg A; Karck M
    Int J Cardiol; 2008 Feb; 124(1):22-6. PubMed ID: 17442433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging.
    Bomatí-Miguel O; Morales MP; Tartaj P; Ruiz-Cabello J; Bonville P; Santos M; Zhao X; Veintemillas-Verdaguer S
    Biomaterials; 2005 Oct; 26(28):5695-703. PubMed ID: 15878375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast agents in magnetic resonance imaging: development and problems].
    Xu YK
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):769-71. PubMed ID: 12297425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of the pancreas: 1.5T versus 3T.
    Edelman RR
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):349-53, vi. PubMed ID: 17893054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.